GLAXO - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 3.5
| Stock Code | GLAXO | Market Cap | 39,959 Cr. | Current Price | 2,360 ₹ | High / Low | 3,516 ₹ |
| Stock P/E | 40.2 | Book Value | 101 ₹ | Dividend Yield | 1.78 % | ROCE | 62.6 % |
| ROE | 46.4 % | Face Value | 10.0 ₹ | DMA 50 | 2,423 ₹ | DMA 200 | 2,551 ₹ |
| Chg in FII Hold | -0.01 % | Chg in DII Hold | -0.02 % | PAT Qtr | 277 Cr. | PAT Prev Qtr | 253 Cr. |
| RSI | 44.2 | MACD | -10.1 | Volume | 1,10,064 | Avg Vol 1Wk | 1,35,015 |
| Low price | 2,218 ₹ | High price | 3,516 ₹ | PEG Ratio | -2.03 | Debt to equity | 0.02 |
| 52w Index | 11.0 % | Qtr Profit Var | 21.3 % | EPS | 58.8 ₹ | Industry PE | 30.9 |
📊 GLAXO shows a cautious intraday setup. RSI at 44.2 indicates weak momentum, while MACD is negative (-10.1), suggesting bearish bias. Current price is below both DMA 50 and DMA 200, reflecting short-term weakness. Volume is lower than the weekly average, limiting volatility-driven opportunities.
- 💰 Optimal Buy Price: 2,340–2,350 ₹ (near support zone)
- 📈 Profit-Taking Levels: 2,380 ₹ (first resistance), 2,420 ₹ (next resistance)
- ⚠️ Stop-Loss: 2,320 ₹ (below intraday support)
- ⏳ If Already Holding: Exit near 2,380–2,420 ₹ if RSI approaches 50 or momentum indicators remain negative intraday.
Positive
✅ Strong ROCE (62.6%) and ROE (46.4%) highlight excellent capital efficiency.
✅ Dividend yield of 1.78% provides steady income.
✅ EPS of 58.8 ₹ reflects solid earnings base.
✅ Quarterly PAT growth (277 Cr vs 253 Cr) shows improving profitability.
Limitation
⚠️ High P/E (40.2) compared to industry average (30.9) suggests overvaluation.
⚠️ PEG ratio (-2.03) indicates weak growth relative to valuation.
⚠️ Current price below DMA 50 and DMA 200 signals weak technical trend.
⚠️ Volume is lower than weekly average, reducing intraday opportunities.
Company Negative News
🚫 No major negative news reported recently, though valuation concerns and weak technicals persist.
Company Positive News
📢 Quarterly profit growth highlights operational strength.
📢 Strong ROCE and ROE demonstrate efficient capital use.
Industry
🏭 Industry P/E is 30.9, lower than GLAXO’s 40.2, suggesting relative overvaluation. Pharma sector demand remains steady, but valuation pressures weigh on upside potential.
Conclusion
🔎 GLAXO is a cautious candidate for intraday trading today. Momentum indicators suggest limited upside, with bearish bias from MACD and RSI. Traders should aim for entries near support and exit around resistance levels, maintaining strict stop-loss discipline due to weak technicals.